Ogden Regional Medical Center diligently works to treat breast cancer in northern Utah and the Greater Salt Lake City area. Being diagnosed with breast cancer or finding tumors, whether benign or malignant, is often the source of anxiety for patients. We are proud to offer minimally invasive breast cancer surgery, breast cancer clinical trials and personalized treatment plans.
To learn more about all of our cancer services, call us at (801) 479-2570.
Benign breast tumor treatment
Cryoablation is a highly effective treatment of breast tumors and has been practiced by physicians for the past 15 years. This minimally invasive option allows patients to experience a shorter hospital stay and less time recovering.
Common symptoms of breast tumor may include:
While these symptoms are typical, the degree of severity is subjective and personal. You should discuss this and other signs and symptoms with your physician.
Benefits of cryoablation include:
- Excellent cosmetic results
- Local anesthesia
- In-office procedure
- No tissue deficit
By choosing cryoablation, you avoid general surgery performed in an operating room. You also avoid reconstructive surgery and several days of recovery.
Details of the procedure
The procedure starts with a thin probe being inserted into the tumor through a small incision site in the breast (about three millimeters).
Once the probe is in place, it undergoes a freeze-thaw-freeze cycle, dropping the temperature of the tumor and killing the targeted tissue. This prohibits any future growth and allows the resolution process to begin.
Immediately after the procedure, you may experience swelling due to your body's natural inflammatory response. Some bruising may occur, but will disappear over time.
The tumor will generally be detectable (or palpable) after treatment for three to 18 months, depending upon the size of the original lesion. Over time, it will reduce in size and your body will absorb the ablated tissue, replacing it with healthy tissue.
Resolution time will vary with each patient and is dependent on many physiological factors. Always refer to your physician for your individual expected outcomes.
To speak with a physician about our cryoablation procedure, please call us at (801) 479-2570.
A clinical trial examining the use of cryoablation as an alternative to surgical procedures for treating primary early stage invasive breast cancer is now being conducted at Ogden Regional Medical Center–the only hospital in Utah and among 14 centers across the county participating in this study.
FROST investigators are actively recruiting 200 female patients, 50+ years of age, at 20 locations nationwide. The study will track the breast tumor recurrence rates, assess breast cosmesis post-treatment, record adverse events and provide 5-year follow-up.
Patient eligibility requirements include unifocal primary invasive breast cancer diagnosed by core needle biopsy and maximum tumor size less than or equal to 1.5 cm.
To find out how to enroll in the FROST clinical study, contact our research coordinator Joshua Kunz at (801) 479-2067.